We have investigated the immune response to E1-deleted adenovirus vectors encoding the lacZ gene introduced into the brains of adult mice. Injection of these nonreplicating vectors caused a marked inflammatory response in the brain as assessed by immunocytochemistry and flow cytometry of leukocytes. Infiltrating leukocytes were detectable within 2 days of injection and reached a maximum by 9 days. Thereafter, the number of infiltrating cells decreased, but a small number persisted in the brain until day 60. Between 2 and 4 days after injection, the percentage of CD8+ cells detectable increased whereas the percentage of CD4+ cells present in the infiltrating population did not significantly increase until day 6, peaking on day 15. Activated ...
Lentiviral vectors are promising tools for gene therapy in the CNS. It is therefore important to cha...
Lentiviral vectors are promising tools for gene therapy in the CNS. It is therefore important to cha...
We have investigated the in vivo dynamics of an adenovirus-based, LacZ expressing vector, RAd36, at ...
We have investigated the humoral immune response to E1-deleted adenovirus vectors encoding the lacZ ...
We have investigated the humoral immune response to E1-deleted adenovirus vectors encoding the lacZ ...
E1-deleted adenoviral vectors expressing the bacterial beta-galactosidase gene were inoculated into ...
In many organs, E1-deleted human adenovirus vectors trigger antiviral T cell responses which limit t...
We report that injecting an E1-deleted, non-replicating, human adenovirus type 5 vector into the bra...
Nonreplicating adenovirus vectors are being developed as vehicles for the delivery of therapeutic ge...
Nonreplicating adenovirus vectors are being developed as vehicles for the delivery of therapeutic ge...
Non-replicating adenovirus vectors are being developed as vehicles for gene transfer into cells of t...
A major disadvantage of first generation adenoviral vectors for gene therapy in the brain is the imm...
In this paper a detailed protocol is presented for neuroscientists planning to start work on first g...
The central nervous system (CNS) is a site of relative immunological privilege; despite this it can ...
The central nervous system (CNS) is a site of relative immunological privilege; despite this it can ...
Lentiviral vectors are promising tools for gene therapy in the CNS. It is therefore important to cha...
Lentiviral vectors are promising tools for gene therapy in the CNS. It is therefore important to cha...
We have investigated the in vivo dynamics of an adenovirus-based, LacZ expressing vector, RAd36, at ...
We have investigated the humoral immune response to E1-deleted adenovirus vectors encoding the lacZ ...
We have investigated the humoral immune response to E1-deleted adenovirus vectors encoding the lacZ ...
E1-deleted adenoviral vectors expressing the bacterial beta-galactosidase gene were inoculated into ...
In many organs, E1-deleted human adenovirus vectors trigger antiviral T cell responses which limit t...
We report that injecting an E1-deleted, non-replicating, human adenovirus type 5 vector into the bra...
Nonreplicating adenovirus vectors are being developed as vehicles for the delivery of therapeutic ge...
Nonreplicating adenovirus vectors are being developed as vehicles for the delivery of therapeutic ge...
Non-replicating adenovirus vectors are being developed as vehicles for gene transfer into cells of t...
A major disadvantage of first generation adenoviral vectors for gene therapy in the brain is the imm...
In this paper a detailed protocol is presented for neuroscientists planning to start work on first g...
The central nervous system (CNS) is a site of relative immunological privilege; despite this it can ...
The central nervous system (CNS) is a site of relative immunological privilege; despite this it can ...
Lentiviral vectors are promising tools for gene therapy in the CNS. It is therefore important to cha...
Lentiviral vectors are promising tools for gene therapy in the CNS. It is therefore important to cha...
We have investigated the in vivo dynamics of an adenovirus-based, LacZ expressing vector, RAd36, at ...